Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Munro

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
Cell Death & Disease|November 8, 2023
Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cellsYakinthi Chrisochoidou, Rajat Roy, Pooyeh Farahmand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but AlsoJohn M S Bartlett, Christopher C McConkey, Alison F Munro, et al.
Cancer Research|December 5, 2024
Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in MelanomaCatriona A Ford, Dana Koludrovic, Patricia P Centeno, et al.
Cancer Research|August 21, 2021
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and TolerabilityCarolin Temps, Daniel Lietha, Emily R Webb, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
Cell Death & Disease|November 8, 2023
Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cellsYakinthi Chrisochoidou, Rajat Roy, Pooyeh Farahmand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but AlsoJohn M S Bartlett, Christopher C McConkey, Alison F Munro, et al.
Cancer Research|December 5, 2024
Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in MelanomaCatriona A Ford, Dana Koludrovic, Patricia P Centeno, et al.
Cancer Research|August 21, 2021
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and TolerabilityCarolin Temps, Daniel Lietha, Emily R Webb, et al.
Pageof 17